OBJECTIVES: 1. Characterize patient visits for chronic rhinosinusitis on the basis of age, gender, race, diagnostic services, and medication use. 2. Evaluate regional differences in patient visits for chronic rhinosinusitis. STUDY DESIGN: Analysis of cross-sectional survey data from two national databases of ambulatory medical encounters.
M ore than 18 million office visits are made to physicians in the United States for chronic rhinosinusitis (CRS) each year. 1 Additionally, there are approximately 1.2 million annual visits to hospital outpatient departments, emergency rooms, and walk-in clinics. 2 A study of more than 200,000 adult members of a single health maintenance organization demonstrated that patients with a diagnosis of CRS made 43 percent more outpatient visits and 25 percent more urgent care visits than did other enrollees, with an estimated treatment cost of $2609 per patient annually. 3 As one of the top 10 most costly physical health conditions affecting American businesses, CRS has a considerable economic impact on residents of the United States. 4 The economic burden of CRS is calculated at greater than $5.8 billion annually. 5 The cost of medication alone, including over-the-counter remedies, nasal steroid sprays, and antibiotics, averages from $629 to $1220 per patient per year. 6 This disease also has an immense impact in terms of quality of life and productivity. 7, 8 According to the National Health Interview Survey (NHIS), approximately 12.5 million lost workdays and 58.7 million restricted activity days were attributed to CRS between 1990 and 1992. 9 Per patient, CRS accounts for an estimated 4.8 days of missed work per year. 10 Nonetheless, our current understanding of the epidemiology of this disease is relatively sparse. According to the 2006 NHIS, a complex sample survey involving annual in-home interviews of 100,000 noninstitutionalized US adults, rhinosinusitis is estimated to affect 31 million people (14% of the adult population) annually. 11 Although this survey is based upon self-report measures that may underestimate true prevalence rates, it does demonstrate several interesting trends within the US population. Most notably, this disease appears to have a disproportionate effect on women and residents in the South. In 2006, the national annual prevalence rate of self-reported CRS was 17 percent in women compared with 10 percent in men. Compared with other groups, white non-Hispanic women and black non-Hispanic women were the most likely to have been told they have CRS. Regional frequencies ranged from 9.8 percent in the West to 17 percent in the South. 11 This regional variation may be partially attributed to higher rates of allergic fungal rhinosinusitis (AFRS) in the South. A survey of 20 otolaryngological practices throughout the United States found that the diagnosis of AFRS was much more frequent in the Southern practices, accounting for 10 to 23 percent of all endoscopic sinus procedures performed there compared with 0 to 4 percent in other locations. 12 The goal of this study was to evaluate regional differences in patient visits for CRS, including age, gender, diagnostic services, and medication use. This approach is distinct from previous studies in that it utilizes physicianderived data, rather than relying upon self-reported diagnoses. Additionally, it explores current diagnostic and therapeutic patterns for this disease. This analysis was based on data from two large annual national surveys, the National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS). Although this study was designed to provide estimates of disease burden on the US population, it does not report measures of incidence and prevalence. Such measures cannot be derived from sampling surveys based on physician encounters.
METHODS
An analysis of cross-sectional survey data from two national databases, the NAMCS and the NHAMCS, was conducted. The NAMCS collects data annually from a nationally representative sample of patient visits to nonfederal officebased physicians who are primarily engaged in direct patient care. Visits to free-standing clinics, community health centers, private offices, and health maintenance organizations are included in the survey. Physicians in the specialties of anesthesiology, pathology, and radiology are excluded from the survey. Approximately 3000 physicians participate in the survey each year. The NAMCS utilizes a three-stage design: First, a probability sample of primary sampling units is taken; next, physician practices within the primary sampling unit are sampled; and, finally, patient visits within the physician practices are sampled. During a random oneweek reporting period, each physician (or his or her office staff) records data for a systematic random sample of visits on an encounter form.
The NHAMCS collects data annually on a national sample of visits to nonfederal hospital emergency and outpatient departments. Noninstitutional general and short-stay hospitals are included in the survey, whereas federal, military, Veterans Administration, and institutional hospitals are excluded. The survey uses a four-stage probability design: First, samples of primary sampling units within geographically defined areas are taken; next, hospitals within these areas are sampled; then, clinics within the outpatient departments and emergency service areas within the emergency departments of these hospitals are sampled; and, finally, patient visits to these clinics and emergency service areas are sampled. Hospital staff complete encounter forms on a systematic random sample of patient visits during a 4-week reporting period.
Visits to physicians in all specialties were included in the analysis, except those excluded by survey design (eg, anesthesiology, radiology, and pathology). For the NAMCS, detailed information regarding physician specialty was available for each patient visit; during the analysis, Family Practice, Internal Medicine, and General Practice were grouped together as "Primary Care" because of the similarities between these specialties. For the Outpatient subsection of the NHAMCS, data regarding physician specialty were limited to five categories which delineated the type of clinic in which the visit took place: General Medicine, Surgery, Pediatrics, Obstetrics and Gynecology, and Other. For the Emergency Department subsection of the NHAMCS, all providers were presumed to be in Emergency Medicine because no data on provider specialty were available.
For both the NAMCS and NHAMCS, as many as three diagnoses can be linked to each visit, based on International Classification of Diseases, Ninth Revision (ICD)-9 diagnostic codes. These codes represent the patient disease(s) that served as a focus for that particular visit; they do not reflect a complete list of comorbidities for that patient. A diagnosis of CRS was identified by the ICD-9 code for chronic sinusitis (473). Table 1 provides a complete list of diseases captured by this code.
The analysis included data from 2003 to 2006, which were the most recent data available. Visits were weighted to generate national estimates of care. Both the NAMCS and NHAMCS have a built-in weighting program that accounts for variation in sampling on the basis of geographic location, provider nonresponse, and differences in patient loads. Visits were stratified by geographic region (Northeast, Midwest, South, and West).
For both the NAMCS and NHAMCS, data are collected on patient demographics; symptoms; diagnoses; diagnostic and therapeutic services provided; and medications ordered, supplied, administered, or continued. Up to eight medications can be listed for each patient visit. Data from both surveys were combined; therefore, only those variables that overlapped between both surveys for all years of the study were available for analysis. Variables were selected for analysis based on a priori hypotheses regarding their rele- vance to the diagnosis of interest. Patient age, gender, race identification, setting type (eg, non-hospital-based outpatient clinic vs hospital-based outpatient department vs emergency department), whether diagnostic services were ordered or provided, number of medications ordered or continued, and physician specialty were included in the analysis. The number of medications ordered or provided at the visit was arbitrarily dichotomized into 0-3 medications and 4-8 medications for ease of analysis. Detailed information regarding the type of diagnostic service ordered (eg, CT scan, MRI, ultrasound) was not available for all years of the study period. Therefore, visits were defined by whether or not diagnostic services of any type were ordered during the visit. Note that these services may have been provided for CRS or any other diagnosis addressed during the visit. Similarly, medications ordered or continued during the visit may have been related to CRS or any other diagnosis linked to the visit. Analyzing the specific type of medication(s) prescribed at each visit was outside the scope of this analysis, given that it would involve nearly 40,000 medication entries.
Data were analyzed with Pearson 2 tests using the SPSS 16.2 Complex Samples Module (SPSS for Windows, Rel. 16.2. 2008, SPSS Inc, Chicago, IL), taking into account the complex survey design and multiple time periods. Estimates were considered unreliable if they were based on fewer than 30 (unweighted) patient visits or if they had a relative standard error (RSE) greater than 30 percent. 13 This study was performed in accordance with a protocol approved by the University of California, San Diego Human Research Protections Program.
RESULTS
From 2003 to 2006, a total of 4617 unweighted patient visits for CRS were identified from the NAMCS and NHAMCS databases. With application of weights to this sample, these visits represent 91.2 million national visits for CRS over the study period. This represents approximately 1.95 percent of all visits for ambulatory care in the US.
Primary care specialties, including Internal Medicine, General Practice, Family Practice, and Pediatrics, were involved in the majority of patient visits for CRS ( Table 2 ). According to the NAMCS data, which were the only subset that allowed detailed analysis of physician specialty, approximately one third of ambulatory care visits for CRS involved otolaryngologists. Approximately 20 percent of all visits for CRS took place in an emergency department. No statistically significant difference was seen between regions for setting type (eg, non-hospital-based outpatient clinic vs hospital-based outpatient department vs emergency department) (Pearson 2 ϭ 50.7, F ϭ 2.1, df ϭ 3.4, 2543, P ϭ 0.88).
Characteristics of patient visits for CRS by geographic region are shown in Table 3 . The mean patient age was 35.6 years (SE 0.782). No regional differences were seen in age when stratified into quartiles (ie, 0-25 years, 26-50 years, 51-75 years, 76ϩ years). Women accounted for the majority of visits to all regions, with a female-to-male ratio of 3:2.
Although the majority of visits for all regions involved patients identified as White (83%-92%), a significantly higher proportion of CRS visits in the South involved African Americans (Pearson 2 ϭ 69.5, F ϭ 6.7, df ϭ 2.8, 2118, P Ͻ 0.01) compared with other regions. In the Northeast, Midwest, and West, African Americans accounted for 7.4 percent (95% confidence interval [CI], 5.1-10.6), 6.6 percent (95% CI, 4.4-9.8), and 7.0 percent (95% CI, 4.1-11.5) of all visits for CRS, respectively. In comparison, in the South, this group accounted for 14.4 percent (95% CI, 11.0-18.7) of all visits for CRS.
Significantly fewer diagnostic services were provided or ordered at the patient visits in the Northeast (Pearson 2 ϭ 64.8, F ϭ 4.0, df ϭ 4.3, 3247, P Ͻ 0.01). Diagnostic services were ordered or provided at only 87.6 percent (95% CI, 80.1-92.6) of all visits for CRS in the Northeast, compared with 93.9 to 95.0 percent (95% CI, 91.2-96.7) of visits in the other regions. No statistically significant difference between regions was seen for the variable Other Imaging, which includes any imaging test ordered that is not specified elsewhere on the survey (Pearson 2 ϭ 14.9, F ϭ 2.0, df ϭ 2.8, 2120, P ϭ 0.11).
Providers in the Northeast were also significantly less likely to order or renew more than three medications at the patient visit (Pearson 2 ϭ 54.0, F ϭ 3.1, df ϭ 2.6, 1930, P Ͻ 0.05). They did so at only 12.4 percent of visits (95% CI, 9.0-16.9) compared with 22.2 to 26.2 percent (95% CI, 16.8-34.1) of visits for the other regions.
DISCUSSION
Dramatic regional variations in health care practice have been reported for rates of lower extremity revascularization, carotid endarterectomy, back surgery, and radical prostatectomy, 14 as well as the frequency of diagnostic testing and the rate of minor surgical procedures. 15 Interestingly, Fisher et al 16 demonstrated that, although Medicare enrollees in higher-spending regions receive more care than those in lower-spending regions, they do not have better health outcomes or satisfaction with care.
This study demonstrates that CRS, a disease that is frequently seen in the offices of both primary care physicians and otolaryngologists, is similarly associated with regional variation. Over a four-year period, differences can be seen between the Northeastern, Midwestern, Southern, and Western regions of the United States in terms of patient demographics, utilization of diagnostic services, and prescription patterns. Given the high prevalence of this disease, such variation could have a significant impact upon health care expenditures. Additionally, because approximately 70 percent of visits for CRS involve the use of at least one antibiotic, 17 these variations may result in regional differences in antibiotic resistance, with significant effects upon disease progression and management. Several studies have been performed in recent years in an attempt to determine the utility and cost-effectiveness of various diagnostic and treatment approaches to CRS. The findings of this study should emphasize the importance of utilizing evidencebased medicine in the management of this common disorder to achieve greater standardization of care throughout the United States.
According to the 2006 NHIS, rhinosinusitis is estimated to affect approximately 14 percent of the adult US population annually. 11 In comparison, our study found that CRS accounted for approximately 2 percent of all ambulatory visits in the United States. Although these two rates cannot be directly compared, given that the NAMCS and NHAMCS provide only an indirect measure of prevalence, it is surprising that CRS is responsible for such a small percentage of physician encounters. This discrepancy may be due to differences in reporting measures. Although the NHIS does provide a useful estimate of disease prevalence, it relies upon self-report, with no physician-based confirmation of reported diagnoses. Additionally, CRS may re- quire fewer routine patient visits compared with other chronic diseases, or it may be under-reported in ICD-9 coding. This latter possibility may be particularly relevant for the elderly population, who accounted for only a small percentage of CRS visits in all regions. Thus, rhinosinusitistype symptoms may be overshadowed by other, more serious medical problems and therefore not addressed by the patient or the physician or, if addressed, not coded. Alternatively, CRS may be less prevalent within this age group. Differences observed in CRS visit rates for African Americans likely reflect overall geographic differences in terms of this population, rather than a process specific to CRS. On the basis of data from the 2000 US Census, more than half (54.8%) of the African American population lives in the South compared with 17.6 percent in the Northeast, 18.8 percent in the Midwest, and 8.9 percent in the West. The ratio of these rates corresponds roughly with the ratio in visit rates seen in this study, with both the African American population and the number of visits for CRS being approximately twice as high in the South as in other regions.
Additionally, Caucasians are overrepresented in this patient population. Eighty-three to 92 percent of all visits for CRS involved patients identified as White, whereas the 2000 US Census showed that only 75 percent of the US population identified themselves as part of this racial group. Whether this reflects differences in access to care or true differences in disease prevalence is outside the scope of this article but certainly deserves additional attention.
Although the NAMCS and NHAMCS provide a large, nationally representative database with more than 4000 unweighted CRS patient visits during the study period, this study has several limitations that are related to the nature of the NAMCS and NHAMCS survey instruments. First, the sampling of these surveys is based on visits, not individual patients, thereby allowing us to only draw indirect measures of prevalence rates. Individuals with CRS who do not seek medical care are not represented in this study, nor are those patients who have previously been diagnosed with this condition but are not actively being treated for it at the visit. In addition, owing to the sampling design of the survey, certain groups may be overrepresented, such as frequent users of care. Because we included visits that were focused solely upon CRS and those in which other diagnoses were also addressed, the study design also limits our ability to associate specific diagnostic tests or medications directly with the diagnosis of CRS. Finally, previous research has demonstrated that ICD-9 coding may be used with some confidence for broad cause groupings but accuracy declines for more specific, focused codes 18 ; therefore, some bias may be introduced by relying on these codes for a given diagnosis.
Thus, significant regional variations exist for chronic rhinosinusitis in terms of patient characteristics, diagnosis, and management. Of particular interest are the differences in medical practice seen between the Northeast and the other regions of the United States, with physicians in the Northeast utilizing fewer diagnostic services and prescrib-ing or continuing fewer medications per visit. These findings should encourage further investigation into regional differences in the diagnosis and treatment of CRS, because they could have a significant impact on the management of this disease.
